Cash From Financing Activities - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Cash from Financing Activities Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Cash from Financing Activities
-â‚Ş82.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Cash from Financing Activities
-$2.3B
CAGR 3-Years
-11%
CAGR 5-Years
-10%
CAGR 10-Years
0%
Redhill Biopharma Ltd
NASDAQ:RDHL
Cash from Financing Activities
$24.5m
CAGR 3-Years
-32%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash from Financing Activities
$90k
CAGR 3-Years
4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Cash from Financing Activities
-$1.7m
CAGR 3-Years
-31%
CAGR 5-Years
-77%
CAGR 10-Years
N/A
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash from Financing Activities
-â‚Ş25.5m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is InterCure Ltd's Cash from Financing Activities?
Cash from Financing Activities
-82.9m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Cash from Financing Activities amounts to -82.9m ILS.

Back to Top